|
2023
|
Invention
|
Solid state forms of tivozanib and process for preparation thereof. The present disclosure encomp... |
|
|
Invention
|
Vial adapter and vial adapter system and method. A vial adapter may include a body extending from... |
|
2021
|
Invention
|
Solid state forms of mavacamten and process for preparation thereof.
The present disclosure enco... |
|
2020
|
Invention
|
Crystalline lorlatinib : fumaric acid and solid state form thereof. The present disclosure relate... |
|
2019
|
Invention
|
Solid state forms of sugammadex sodium.
The present disclosure relates to solid state forms of S... |
|
|
Invention
|
Solid state forms of sugammadex sodium. The present disclosure relates to solid state forms of Su... |
|
|
Invention
|
Solid state forms of lorlatinib and their preparation.
The present disclosure relates to Lorlati... |
|
|
Invention
|
Solid state forms of lorlatinib and their preparation. The present disclosure relates to Lorlatin... |
|
2018
|
Invention
|
Salts and solid state forms of plinabulin. The present disclosure relates to Plinabulin solid sta... |
|
|
Invention
|
New crystalline polymorphs of bardoxolone methyl. Disclosed are crystalline polymorphs of Bardoxo... |
|
2017
|
Invention
|
Solid state forms of crisaborole. Solid state forms of Crisaborole and salts thereof, processes f... |
|
|
Invention
|
Solid state forms of crisaborole.
Solid state forms of Crisaborole and salts thereof, processes ... |
|
|
Invention
|
Solid state forms of neratinib and salts thereof. Solid state forms of Neratinib and salts thereo... |
|
|
Invention
|
Solid state forms of nilotinib salts. The present disclosure relates to solid state forms of Nilo... |
|
2016
|
Invention
|
Processes for the preparation of apremilast and intermediates thereof. Disclosed are processes fo... |
|
|
Invention
|
Solid state forms of cediranib maleate. The present disclosure relates to solid state forms of Ce... |
|
|
G/S
|
Pharmaceutical products. |
|
2012
|
Invention
|
Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate.
New polymorphic fo... |
|
2011
|
Invention
|
Crystal forms of o-desmethylvenlafaxine fumarate. Provided are crystalline forms of O-desmethylve... |
|
|
Invention
|
Solid state forms of fosamprenavir calcium salt and process for preparation thereof. The present ... |
|
2010
|
Invention
|
Polymorphs of etravirine and processes for preparation thereof. The present invention provides no... |
|
|
Invention
|
Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof. New polymo... |
|
|
Invention
|
Process for preparing (r)-7v-benzyl-2- (benyloxycarbonylamino)-s-methoxypropionamide. (R)-Λ/-benz... |
|
2009
|
Invention
|
Method for preparation of o-desmethylvenlafaxine using polythiolates.
This invention relates to ... |
|
|
G/S
|
Pharmaceutical and veterinary products. |
|
|
Invention
|
Polymorphic and amorphous forms of lacosamide and amorphous compositions. The present invention r... |
|
|
G/S
|
Soaps and cosmetic products. Pharmaceutical preparations; sanitary preparations for
medical purp... |
|
2008
|
Invention
|
Amorphous forms of retapamulin. The present invention is directed to amorphous forms of retapamul... |
|
|
Invention
|
Process for preparing crystalline calcium mupirocin dihydrate. Provided herein are methods of pre... |
|
|
Invention
|
Novel rotigotine salts. The present invention relates to new salts of N,N-disubstituted aminotetr... |
|
|
Invention
|
Preparation of crystalline rotigotine base. The present invention relates to processes of prepari... |
|
|
Invention
|
Polymorphic forms of ( s ) -rotigotine hydrochloride. The present invention is concerned with new... |
|
|
Invention
|
Processes for preparing pharmaceutical compounds. The present invention relates to the preparatio... |
|
|
Invention
|
New forms of deferasirox. The present invention is directed to pharmaceutical formulations compri... |
|
|
Invention
|
Methods for preparing bortezomib and intermediates used in its manufacture. Provided herein are m... |
|
|
Invention
|
Gel compositions comprising urea derivatives. The invention relates to gel composition comprising... |
|
|
Invention
|
Gel forming compounds. Compounds of general formula (Ia) or (Ib): general formula (Ia) or (Ib): w... |
|
|
Invention
|
Solid oral dosage form containing bicalutamide and method of preparation. A tablet comprising bic... |
|
2007
|
Invention
|
Pharmaceutical composition of zolpidem. A pharmaceutical composition comprising a Zolpidem hemita... |
|
|
Invention
|
Pharmaceutical composition of memantine.
Present invention provides pharmaceutical composition c... |
|
|
Invention
|
Pharmaceutical composition of memantine. Present invention provides pharmaceutical composition co... |
|
|
Invention
|
Pharmaceutical formulation of risedronate. The present invention relates to an oral pharmaceutica... |
|
|
Invention
|
New polymorphic forms of pregabalin. The present invention is concerned with new polymorphic form... |
|
|
Invention
|
Process for the preparation of montelukast. A process of preparing montelukast, or a pharmaceutic... |
|
|
Invention
|
Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate. The present inventi... |
|
|
Invention
|
Polymorphic forms of spirapril hydrochloride. The present invention is concerned with new polymor... |
|
|
Invention
|
Process for preparing pregabalin and its opposite enantiomer. The invention relates to the prepar... |
|
|
Invention
|
Process and product. The present invention relates to an improved process for isolation and purif... |
|
|
Invention
|
Pharmaceutical formulation comprising donepezil.
The present invention relates to a pharmaceutic... |
|
|
Invention
|
Pharmaceutical formulation comprising donepezil. The present invention relates to a pharmaceutica... |
|
|
Invention
|
Impurities of donepezil.
The present invention relates to impurities of donepezil, or a pharmace... |
|
|
Invention
|
Pharmaceutically acceptable salts and polymorphic forms.
The present invention is concerned with... |
|
2006
|
G/S
|
Produits pharmaceutiques. |
|
|
G/S
|
Pharmaceutical preparations. |
|
2005
|
G/S
|
Chemicals used in industry namely, active pharmaceutical ingredients used for the manufacture of ... |
|
|
G/S
|
Pharmaceutical and veterinary preparations. |
|
2004
|
G/S
|
Produits pharmaceutiques et vétérinaires. |
